Recent insights into novel roles of klotho in vascular biology make this primarily kidney-
derived protein a possible candidate to form a link between chronic kidney disease and …

Inflammation at both systemic and local intraperitoneal levels commonly affects peritoneal
dialysis (PD) patients. Interest in inflammatory markers as targets of therapeutic intervention …

The uremia‐induced inflammatory environment in end‐stage renal disease (ESRD) patients
is associated with premature T‐cell aging resulting in a defective T‐cell immunity. As kidney …

Background End stage renal disease (ESRD) patients receiving hemodialysis (HD) have a
higher risk of peptic ulcer bleeding (PUB). Aims Whether ESRD patients receiving peritoneal …

Background Residual renal function (RRF) has been identified as the most important
component in dialysis adequacy and has a strong effect on clinical outcomes. This justifies …

End-stage renal disease (ESRD) patients have a defective T-cell-mediated immune system
which is related to excessive premature ageing of the T-cell compartment. This is likely to be …

Background High serum concentrations of the protein-bound uremic retention solutes p-
cresyl sulfate (PCS) and indoxyl sulfate (IndS) and inflammation are associated with …

Atrial fibrillation is a significant comorbidity in patients with CKD and ESRD with important
prognostic implications. More research is needed to understand the mechanisms that …

Background Treatment with recombinant human growth hormone (GH) is the standard
therapy for short stature in children with chronic kidney disease (CKD). However, concerns …

Objectives: We aimed to evaluate oxidative stress [8-hydroxydeoxyguanosine (8-OHdG),
malondialdehyde (MDA)] endothelial damage [asymmetric dimethylarginine (ADMA)] and …